ClinicalTrialsFinder
RecruitingPhase 4NCT03346772

Study of Immune Responses to Influenza Vaccination

Sponsor

University of Pennsylvania

Enrollment

75 participants

Start Date

Oct 20, 2017

Study Type

INTERVENTIONAL

Conditions

Influenza vaccination

Summary

Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Influenza vaccination for people with influenza vaccination. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALInfluenza vaccination

Adults will receive one intramuscular dose of seasonal quadrivalent inactivated influenza vaccine, as indicated for standard of care.

Locations(1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03346772

Related Trials

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

NCT043678831 location

Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility

NCT073104721 location